UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Rehabilitation of patients with hallucinatory-paranoid disorders in mixed dementia

Type of Article

In the Section

Index UDK:

Abstract

The study involved 72 patients with hallucinatory-paranoid disorders (HPD) in mixed dementia, who were included in the main group. 61 patients with mixed dementia without psychotic disorders participated in control group. The study of the clinical and psychopathological manifestations of HPD and the cha rac teris tics of cognitive impairment in mixed dementia allowed the development of the program of comprehensive personified psychosocial rehabilitation based on the principles of a comprehensive, diff erentiated and personality-oriented approach, and includes a combination of biological and psychosocial effects on all etiopathogenetic links in the development and progression of mixed dementia. The main targets in the developing system of therapy and rehabilitation were: non-cognitive psychopathological disorders, cognitive disorders, psychosocial defi ciency, concomitant somatic and neurological diseases. Eff ectiveness has been proven of the developed program of therapy and rehabilitation of patients with HPD in mixed dementia.

Pages

References

  1. Maruta N. A. Early intervention in dementia: problems and solutions // Ukr. med. chasopis. 2019. Q10. URL: https://www.umj.com.ua/wp/wp-content/uploads/2019/04/Cognit.pdf?upload=.
  2. World Alzheimer Report 2010. The Global Economic Impact of Dementia: London, 2010. URL: https://www.alz.co.uk/research/world-report-2010.
  3. Unified clinical protocol for primary, secondary (specialized), tertiary (highly specialized) and palliative care. Dementia / edited by A.O. Havryliuk. К., 2016. 57 с.
  4. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project / A. Wimo, L. Jönsson, A. Gustavsson [et al.] // Int. J. Geriatr Psychiatry. 2011. Vol. (8). Р. 825—832. DOI: https://doi.org/10.1002/gps.2610.
  5. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: Summary of WHO recommendations / T. Dua, C. Barbui, N. Clark [et al.] // PLoS Medicine, 2011, 15 Nov, 8 (11): e1001122. DOI: https://doi.org/10.1371/journal.pmed.1001122.
  6. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alz hei mer’s Association workgroups on diagnostic guidelines for Alz hei mer’s disease / G. M. McKhann, D. S. Knopman, H. Chert kow [et al.] // Alzheim dement. 2011. Vol. 7 (3). P. 263—269. DOI: https://doi.org/10.1016/j.jalz.2011.03.005.
  7. Management of behavioral problems in Alzheimer’s disea se / S. Gauthier, J. Cummings, C. Ballard [et al.] // Int Psychogeriatr. 2010. Vol. 22 (3). P. 346—372. DOI: https://doi.org/10.1017/S1041610209991505.
  8. Risk factors and preventive interventions for Alzheimer disease: state of the science / M. L. Daviglus, B. L. Plassman, A. Pirzada [et al.] // Archives of Neurology. 2011. Vol. 68 (9). P. 1185—1190. DOI: https://doi.org/10.1001/archneurol.2011.100.
  9. Evolving attitudes to Alzheimer’s disease among the general public and caregivers in Europe: findings from the Impact Survey / [M. Wortmann, S. Andrieu, J. Mackell, S. Knox] // Journal of Nutrition, Health and Aging. 2010. Vol. 14. P. 531—536. DOI: https://doi.org/10.1007/s12603-010-0264-x.
  10. The Coping with Caregiving group program for Chinese caregivers of patients with Alzheimer’s disease in Hong Kong / A. Au, S. Li, K. Lee [et al.] // Patient Education and Counseling. 2010. Vol. 78. P. 256—260. DOI: https://doi.org/10.1016/j.pec.2009.06.005.
  11. 2011 Alzheimer’s disease facts and figures / Alzhei mer’s Association // Alzheimers Dement. 2011. Vol. 7(2). P. 208—244. DOI: https://doi.org/10.1016/j.jalz.2011.02.004.
  12. Non-pharmacological interventions in dementia / Simon Douglas, Ian James and Clive Ballard // Advances in Psychiatric Treatment. 2010. Vol. 10 (3). P. 178—179. DOI: https://doi.org/10.1192/apt.10.3.171.
  13. Levin O. S. Algorithms of diagnostics and treatment of dementia. М. Medpressinform, 2010. 186 с.
  14. Barnes D. E., Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence // Lancet Neurology. 2011. Vol. 10 (9). Р. 819—828. DOI: https://doi.org/10.1016/S1474-4422(11)70072-2.
  15. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging / [J. E. Ahlskog, Y. E. Geda, N. R. Graff-Radford, R. C. Petersen] // Mayo Clinic Proceedings. 2011. Vol. 86 (9). P. 876—884. DOI: https://doi.org/10.4065/mcp.2011.0252.
  16. Caregiver time and cost of home care for Alzheimer’s disease: a clinic-based observational study in Beijing, China / [Huali Wang, Tianfei Gao, Anders Wimo, Xin Yu] // Ageing International. 2010. Vol. 35 (2). P. 153—165. DOI: https://doi.org/10.1007/s12126-010-9056-1.
  17. Folstein M. F., Folstein S. E, McHugh P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician // J. Psychiatr. Res. 1975. Vol. 12 (3). Р. 189—198. DOI: https://doi.org/10.1016/0022-3956(75)90026-6.
  18. Nasreddine Z. S. The Montreal Cognitive Assessment MoCA: a brief screening tool for mild cognitive impairment // J. Am. Geriatr. Soc. 2005. Vol. 53 (4). Р. 695—699. DOI: https://doi.org/10.1111/j.1532-5415.2005.53221.x.
  19. Pruszynski J. Non-cognitive symptoms of dementia // Medycznych. 2015. Vol. 7. Р. 477—481.
  20. Reisberg B., Auer S. R., Monteiro I. M. Behavioral patho logy in Alzheimer’s disease (BEHAVE-AD) rating scale // Int. Psychogeriatr. 1996. Vol. 8 (3). P. 301—308. DOI: https://doi.org/10.1097/00019442-199911001-00147.
  21. Antomonov, M. Yu. Mathematical processing and analysis of biomedical data. Kiev, 2006. 556 с.